A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection.
about
Advances in structure-based vaccine designWest Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor HNoncytopathic Sindbis virus RNA vectors for heterologous gene expressionStructure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus HemagglutininFlavivirus NS1 Structures Reveal Surfaces for Associations with Membranes and the Immune SystemStructural basis of Flavivirus NS1 assembly and antibody recognitionStructure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodiesLarge-scale analysis of B-cell epitopes on influenza virus hemagglutinin - implications for cross-reactivity of neutralizing antibodies.New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusionMutagenesis studies of the H5 influenza hemagglutinin stem loop region.Humanized antibody neutralizing 2009 pandemic H1N1 virus.The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.Passive broad-spectrum influenza immunoprophylaxisAn anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infectionCross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2.A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypesPre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population.Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus.Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in miceAttenuated West Nile virus mutant NS1130-132QQA/175A/207A exhibits virus-induced ultrastructural changes and accumulation of protein in the endoplasmic reticulum.Two distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assemblyTargeting B cell responses in universal influenza vaccine design.RNA virus vectors: where are we and where do we need to go?Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza VirusesInfluenza pharmacotherapy: present situation, strategies and hopes.Prospects of HA-based universal influenza vaccine.Specific polyclonal F(ab')2 neutralize a large panel of highly pathogenic avian influenza A viruses (H5N1) and control infection in mice.Large scale genome analysis shows that the epitopes for broadly cross-reactive antibodies are predominant in the pandemic 2009 influenza virus A H1N1 strain.Novel Platforms for the Development of a Universal Influenza Vaccine.
P2860
Q26824545-322D711A-0221-4588-A124-23A95D1B834AQ27477691-EA73AD4C-5DE2-4466-8803-2D4B367ABE4BQ27485983-0F6DD25E-C5B3-4EED-B1FB-32F3BAF9DAE2Q27677191-E2680E65-0614-418A-A591-61C664A05373Q27681625-BF3AD0C9-5A87-4942-AE63-99E4354213F5Q27681981-8225810D-9B79-4C15-8F53-A8D794F2B879Q28396120-05A8AB24-EAC7-42C0-9E96-B762B75EF9FBQ30217235-ED21054E-7BA0-49D9-A24A-1515E1C065F9Q30355297-09BE8BF4-C302-447B-A084-1D89A70D0473Q30363789-294F558F-07AE-4F24-B985-EED67C923E34Q30364911-1E13CEC1-D6BB-4BEA-9EAF-715EC4C4B7C2Q30365366-1C9DB6C0-2F03-47D8-B1BE-D9224ADE5460Q30367936-D582985A-70E1-4E76-A68D-B05C3B5657D2Q30371674-2C81747D-D5A3-4454-848E-BBE5132E2090Q30404095-D76EBA38-FC4A-45CF-8A07-951AF72B9355Q30410546-71052C22-EC87-43F2-AEBE-63594BE5DB13Q30428692-69FC03F5-D1C1-4B10-B273-02DFB05952E8Q33795001-60A05925-2477-42D6-AEE1-B180B8FD4408Q34770423-DDF8719B-D0D2-4AD0-BE04-7AE1794FC444Q34971370-1F57EF45-BE28-4FDC-A240-398BB20E1555Q34990985-8CA7B3A6-49D4-423B-958B-C12FA95C76F1Q34991051-A0D3DDF0-51E3-483C-8E65-55A87C5D6B37Q35540405-F2B4694C-0A72-4671-99FD-88747221A6E5Q36080373-13EE52B1-422A-46DE-B5BA-92168F5AEAA4Q36432748-50AA409E-0BD7-4C70-A671-BDBD12575C0AQ36434265-F77BF001-8488-46F8-931D-88D1D429966CQ37093491-8D2F314D-08DB-41AD-90A1-5FD995FF13ECQ37857854-D719C092-D27F-4523-8D34-6EAEABDF7F35Q41416400-47593063-81CD-4878-8403-05F620A8AF29Q42228728-623BAF18-E8B8-479C-B25B-91607206A01EQ42834911-3DA4BA90-3A7B-4448-AA91-FA927FCFCF4AQ52599675-2A106AD8-FE0C-486B-99C0-8283654B98B5
P2860
A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A cross-reactive neutralizing ...... c (H1N1) 2009 virus infection.
@ast
A cross-reactive neutralizing ...... c (H1N1) 2009 virus infection.
@en
type
label
A cross-reactive neutralizing ...... c (H1N1) 2009 virus infection.
@ast
A cross-reactive neutralizing ...... c (H1N1) 2009 virus infection.
@en
prefLabel
A cross-reactive neutralizing ...... c (H1N1) 2009 virus infection.
@ast
A cross-reactive neutralizing ...... c (H1N1) 2009 virus infection.
@en
P2093
P2860
P1433
P1476
A cross-reactive neutralizing ...... c (H1N1) 2009 virus infection.
@en
P2093
Chairul A Nidom
Mai thi Quynh Le
Makoto Ozawa
Ritsuko Kubota-Koketsu
Ryo Takano
Saori Sakabe
Taisuke Horimoto
Yoshinobu Okuno
P2860
P304
P356
10.1016/J.ANTIVIRAL.2010.09.007
P577
2010-09-16T00:00:00Z